Vaxxas wins $22m BARDA funding to advance vaccine delivery platform
HD-MAP is a needle-free vaccine patch technology that improves vaccination by producing enhanced patient-doses from limited quantities of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Oct 20
HD-MAP is a needle-free vaccine patch technology that improves vaccination by producing enhanced patient-doses from limited quantities of…
06 Oct 20
Aermony RespiClick (fluticasone propionate inhalation powder), available in three dose options
16 Sep 20
Cutaquig 16.5% Part B Approval for Infusions with Electric and Mechanical Pumps Started September 6th
15 Sep 20
The MIMIX patch technology enhances the effectiveness of vaccine by leveraging sustained release technology to stimulate superior immune…
15 Sep 20
The immunogen was co-developed by researchers at the Vaccine Research Center of the National Institute of Allergy and…
Abbott recently announced a clinical trial of its drug-eluting stent, which it says provides an effective treatment for…
04 Sep 20
The funding will be used by Biofourmis to develop, validate and commercialise several released and unreleased digital therapeutics…
28 Aug 20
The trial will evaluate the effectiveness of MagicTouch PTA sirolimus coated balloon versus standard balloon angioplasty to treat…
27 Aug 20
Vaxess Technologies develops proprietary sustained release smart delivery technologies to meet the need for more efficacious and easy…
26 Aug 20
The microinjection procedure is designed to avoid damaging the structure of the eye by preventing the need for…